Font Size:
a
A
A
Keyword [nucleos(t)ide analogues]
Result: 61 - 72 | Page: 4 of 4
61.
The Expression Of Serum HBV PgRNA In Chronic Hepatitis B Patients Treated With NAs And Its Clinical Significance
62.
Analysis Of Clinical Characteristics Of 243 Cases Of Low Viremia Treated With NAs For Hepatitis B Cirrhosis
63.
Effects Of Hepatitis B Core-relative Antigen And T Cell Receptor Dynamic Changes On Relapse After Discontinuation Of Nucleos(t)ide Analogues Treatment In Chronic Hepatitis B Patients
64.
A Clinical-Effectiveness Study Of Add-On Pegylated Interferon Alfa Therapy In Nucleos(t)ide Analogues Treated HBeAg Negative Chronic Hepatitis B Patients
65.
Clinical Characteristics Of Patients With Hepatitis B Associated Primary Liver Cancer With Low Viral Load
66.
Impact Of Nucleos(t)ide Analogues Therapy On The Metabolic Parameters Of Patients With Chronic Hepatitis B
67.
Clinical Study Of Entecavir In Patients With Chronic Hepatitis B With Low-level Viremia
68.
Clinical Study Of Nucleos(t)ide Analogues In The Treatment Of Patients With Chronic HBV Infection With Normal ALT
69.
The Value Of Serum Anti-HBc Quantification In The Natural Course And Treatment Monitoring Of Patients With Chronic HBV Infection
70.
Cross-sectional Study Of The Middle-aged And Elderly Hepatitis B Cirrhosis Combined Renal Damage
71.
Clinical Efficacy Analysis And Prediction Of Pegylated Interferon In Nucleoside Analogue Experienced Negative HBeAg Chronic Hepatitis B
72.
Response Prediction After The Addition Of Pegylated Interferon Therapy For 48 Weeks In Chronic Hepatitis B Patients With Low-Level HBsAg Previously Treated With Nucleos(t)ide Analogues
<<First
<Prev
Next>
Last>>
Jump to